Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue - PubMed (original) (raw)

Comment

doi: 10.1016/j.jhep.2013.10.030. Epub 2013 Nov 9.

Affiliations

Free article

Comment

Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue

Andrea Mancuso et al. J Hepatol. 2014 Mar.

Free article

No abstract available

PubMed Disclaimer

Comment in

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources